Inhibitory Effects of KP-A159, a Thiazolopyridine Derivative, on Osteoclast Differentiation, Function, and Inflammatory Bone Loss via Suppression of RANKL-Induced MAP Kinase Signaling Pathway
Hye Jung Ihn(Kyungpook National University), Eui Kyun Park(Kyungpook National University)
Cited by 16
Related Papers
Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways
|BMB Reports|2017|18
PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo
|International Journal of Molecular Sciences|2021|12
The guanine nucleotide exchange factor DOCK5 negatively regulates osteoblast differentiation and BMP2-induced bone regeneration via the MKK3/6 and p38 signaling pathways
|Experimental & Molecular Medicine|2025|5
Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
|Animal Cells and Systems|2023|3